Publicaciones

A continuación se referencian las 15 publicaciones más destacadas del grupo de investigación de los últimos 5 años.

(*) Autor correspondencia: (#) igual contribución

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of Hepatitis C Virus in Spain. Palladino C, Ezeonwumelu IJ, Mate-Cano I, Borrego P, Martínez-Román P, Arca de Lafuente S, Resino S, Taveira N, Briz V*. Sci Rep 2020, 10: 13024. DOI: 10.1038/s41598-020-69692-7.

Hepatitis C virus influences HIV-1 viral splicing in coinfected patients. Martínez-Román P, López-Huertas MR, Crespo-Bermejo C, Arca-Lafuente S, Cortegano I, Valle-Millares D, Gaspar ML, Martín-Carbonero, Domínguez-Domínguez L, Ryan P, De los Santos I, De la Fuente Moral S, Fernández-Rodríguez A, Coiras M, Briz V, on behalf of COVIHEP. J Clin Med 2020, 9 (7): 2091. DOI: 10.3390/jcm9072091.

Protist enteroparasites in wild boar (Sus scrofa ferus) and black Iberian pig (Sus scrofa domesticus) in southern Spain: a protective effect on hepatitis E acquisition?
Rivero-Juárez A, Dashti A, López-López P, Salimo Muadica A, Risalde MA, Köster PC, Machuca I, Bailo B, Hernández de Mingo M, Dacal E, García-Bocanegra I, Saugar JM, Calero-Bernal R, González-Barrio D, Rivero A, Briz V, Carmena D. Parasites & Vectors 2020, 13: 281. DOI: 10.1186/s13071-020-04152-9.

Enterocytozoon bieneusi (Microsporidia): identification of novel genotypes and evidence of transmission between sympatric wild boars (Sus scrofa ferus) and Iberian pigs (Sus scrofa domesticus) in Southern Spain. Dashti A, Rivero‐Juarez A, Santín M, López‐López P, Caballero‐Gómez J, Frías‐Casas M, Köster PC, Bailo B, Calero‐Bernal R, Briz V*, Carmena D. Transboundary and Emerging Diseases 2020, 00:1–12. DOI: 10.1111/tbed.13658.

Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV coinfected patients. Martinez‑Gonzalez E, Brochado‑Kith O, Gomez‑Sanz A, Martin‑Carbonero L, Jimenez‑Sousa MA, Martinez‑Roman P, Resino S, Fernandez‑Rodriguez A#, Briz V#. Sci Rep 2020, 10: 11140. DOI: 10.1038/s41598-020-67935-1.

Epidemiological trend of sepsis in patients with hospital admissions related to hepatitis C in Spain (2000-2015): A nationwide study. Alvaro-Meca A, Mate-Cano I, Ryan P, Resino S#, Briz V#*. J Clin Med 2020, 9(6): 1607. DOI: 10.3390/jcm9061607.

Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study. Mate-Cano I, Alvaro-Meca A, Ryan P, Resino S, Briz V*. Eur J Intern Med. 2020, 75:84-92. DOI: 10.1016/j.ejim.2020.02.002. PMID: 32143898.

Nanotechnology: A reality for diagnosis of HCV infectious disease. Arca-Lafuente S, Martínez-Román P, Mate-Cano I, Madrid R, Briz V. Journal of Infection 2020, 80 (1); 8-15. DOI: 10.1016/j.jinf.2019.09.010. PMID: 31580870.

Epidemiological trend of hospitalized acute and recurrent hepatitis C in Spain. Mate-Cano I, Alvaro-Meca A, Ryan P, Díaz A, Martínez-Román P, Sánchez-Carrillo M, Resino S, Briz V*. Annals of Medicine 2019, 51 (1); S68-S69. DOI: 10.1080/07853890.2018.1561622.

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study. López-Huertas MR, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, Sánchez-Carrillo M, Martínez-Román P, Martín-Carbonero L, Ryan P, Domínguez-Domínguez L, Santos ID, Moral SDLF, Benito JM, Rallón N, Alcamí J, Resino S, Fernández-Rodríguez A, Coiras M, Briz V*, on behalf of the Multidisciplinary Group of viral coinfection HIV/Hepatitis (COVIHEP). Sci Rep 2019: 9 (1); 5606. DOI: 10.1038/s41598-019-41788-9. PMID: 30944340.

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal. Palladino C, Ezeonwumelu IJ, Marcelino R, Briz V, Moranguinho I, Serejo F, Velosa JF, Marinho RT, Borrego P, Taveira N. Sci Reps 2018, 8 (1); 12266. DOI: 10.1038/s41598-018-30528-0. PMID: 30116054.

Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study. Palladino C, Sánchez-Carrillo M, Mate-Cano I, Vázquez-Morón S, Jimenez-Sousa MA, Gutiérrez-Rivas M, Resino S, Briz V*. Sci Rep 2017, 7: 289. Autor correspondencia. DOI 10.1038/s41598-017-02968-7. PMID: 28588311.

Frecuencia de sustituciones relevantes asociadas a resistencia en la región NS5A a elbasvir en el virus de la hepatitis C en pacientes con genotipo 1a en España. Palladino C, Esteban-Cartelle B, Mate-Cano I, Sánchez-Carrillo M, Resino S, Briz V*. Enferm Infecc Microbiol Clin 2017, https://doi.org/10.1016/j.eimc.2017.03.008. PMID: 28521955.

NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain. Jimenez-Sousa MA, Gutierrez-Rivas M, Alvaro-Meca A, García-Álvarez M, Harrigan PR, Fedele CG, Briz V, Vázquez-Morón S, Resino S. PlosOne 2016; DOI:10.1371/journal.pone.0163197. PMID: 27685471.

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected Falcon-Neyra L, Palladino C, Navarro Gómez ML, Soler-Palación P, González-Tomé MI, J. de Ory, S, Frick MA, Fortuny C, Noguera A, Bermúdez E, Santos JL, Olbrich P, López-Cortés LF, Neth O, Briz V*. HIV Medicine 2016; 95(24):e3842. DOI: 10.1097/MD.0000000000003842. PMID: 27310962.